1 documents found
Registration Number

0207U006107, 0105U008831 , R & D reports

Title

An application of date on proliferative activity of tumor cells, based on IPO-38 expression, and CD150 expression for prognosis of disease an choosing of appropriate therapy.

popup.stage_title

Head

Sidorenko Svitlana Pavlovna,

Registration Date

16-03-2007

Organization

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology

popup.description2

Our investigation showed that CD150 could be used as a marker of malignant B cells with the phenotype of activated B lymphocytes. Simultaneous expression of CD150 and ІПО-38 gives evidence about aggressiveness of malignant disorders. From this point of view diffuse large B cell lymphoma (DLBCL) with activated phenotype is a more aggressive subtype of DLBCL. Determining of ІПО-38 expression as a marker of proliferating cells could be used in clinic for the monitoring of effectiveness of breast cancer therapy.

Product Description

popup.authors

popup.nrat_date

2020-04-02

R & D report
An application of date on proliferative activity of tumor cells, based on IPO-38 expression, and CD150 expression for prognosis of disease an choosing of appropriate therapy.
Head: Sidorenko Svitlana Pavlovna. An application of date on proliferative activity of tumor cells, based on IPO-38 expression, and CD150 expression for prognosis of disease an choosing of appropriate therapy.. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0207U006107
1 documents found

Updated: 2025-07-02


Роздрукувати цю сторінку